1. Wide local excision
The primary surgical approach, aiming to completely remove the tumor with an adequate margin of surrounding healthy tissue; prognosis is favorable in low-grade disease.
2. Minimally invasive surgical techniques
Laparoscopic or robot-assisted procedures reduce surgical trauma and accelerate recovery while maximizing functional preservation.
3. Radiotherapy
Used preoperatively to reduce tumor volume and postoperatively to decrease local recurrence risk; precision techniques enable target conformity while sparing normal tissues.
4. Chemotherapy strategies
Primarily for high-grade or advanced sarcomas; neoadjuvant chemotherapy may improve resectability and increase the likelihood of successful surgery.
5. Targeted therapy
Agents directed at actionable alterations (e.g., pazopanib) can inhibit angiogenesis and tumor growth, with a generally manageable toxicity profile.
6. Immunotherapy
By activating anti-tumor immunity, immunotherapy offers potential clinical benefit and durable disease control for selected patients with advanced disease.
7. Isolated limb perfusion chemotherapy
High-dose chemotherapy is delivered via an isolated limb circulation, enabling limb salvage and reducing the need for amputation in selected extremity tumors.
8. Pathology-guided treatment
Molecular biomarker testing supports selection of targeted and immunotherapeutic options and enables individualized treatment planning.
9. Multidisciplinary care model
A multidisciplinary team (surgery, medical oncology, radiation oncology, etc.) jointly develops an integrated, personalized treatment strategy.
10. Reconstructive surgery
Flap reconstruction, microvascular anastomosis, and related techniques restore anatomy and function and improve quality of life.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that, without timely and standardized treatment, soft tissue tumors may locally invade critical structures or develop distant metastases, posing a serious threat to life. Early diagnosis and guideline-based therapy are essential to improving outcomes. Individualized treatment planning based on tumor type and stage, together with a multidisciplinary approach, can significantly enhance therapeutic efficacy. Patients are advised to seek medical evaluation and standardized treatment as early as possible.
1. Wide local excision
The primary surgical approach, aiming to completely remove the tumor with an adequate margin of surrounding healthy tissue; prognosis is favorable in low-grade disease.
2. Minimally invasive surgical techniques
Laparoscopic or robot-assisted procedures reduce surgical trauma and accelerate recovery while maximizing functional preservation.
3. Radiotherapy
Used preoperatively to reduce tumor volume and postoperatively to decrease local recurrence risk; precision techniques enable target conformity while sparing normal tissues.
4. Chemotherapy strategies
Primarily for high-grade or advanced sarcomas; neoadjuvant chemotherapy may improve resectability and increase the likelihood of successful surgery.
5. Targeted therapy
Agents directed at actionable alterations (e.g., pazopanib) can inhibit angiogenesis and tumor growth, with a generally manageable toxicity profile.
6. Immunotherapy
By activating anti-tumor immunity, immunotherapy offers potential clinical benefit and durable disease control for selected patients with advanced disease.
7. Isolated limb perfusion chemotherapy
High-dose chemotherapy is delivered via an isolated limb circulation, enabling limb salvage and reducing the need for amputation in selected extremity tumors.
8. Pathology-guided treatment
Molecular biomarker testing supports selection of targeted and immunotherapeutic options and enables individualized treatment planning.
9. Multidisciplinary care model
A multidisciplinary team (surgery, medical oncology, radiation oncology, etc.) jointly develops an integrated, personalized treatment strategy.
10. Reconstructive surgery
Flap reconstruction, microvascular anastomosis, and related techniques restore anatomy and function and improve quality of life.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that, without timely and standardized treatment, soft tissue tumors may locally invade critical structures or develop distant metastases, posing a serious threat to life. Early diagnosis and guideline-based therapy are essential to improving outcomes. Individualized treatment planning based on tumor type and stage, together with a multidisciplinary approach, can significantly enhance therapeutic efficacy. Patients are advised to seek medical evaluation and standardized treatment as early as possible.